Edgewise Therapeutics, Inc. - stock earnings
EWTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -30.1 million USD | ? USD |
| 2023Q3 | -25.7 million USD | ? USD |
| 2023Q2 | -21.5 million USD | ? USD |
| 2023Q1 | -19.7 million USD | ? USD |
| 2022Q4 | -16.8 million USD | ? USD |
| 2022Q3 | -16.7 million USD | ? USD |
| 2022Q2 | -15.6 million USD | ? USD |
| 2022Q1 | -14.5 million USD | ? USD |
| 2021Q4 | -12.7 million USD | ? USD |
| 2021Q3 | -12.9 million USD | ? USD |
| 2021Q2 | -10.4 million USD | ? USD |
| 2021Q1 | -6.8 million USD | ? USD |
| 2020Q4 | -6.3 million USD | ? USD |
| 2020Q3 | -3.6 million USD | ? USD |
| 2020Q2 | -4.0 million USD | ? USD |
| 2020Q1 | -3.2 million USD | ? USD |
EWTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.2 million USD | ? USD |
| 2022 | -15.4 million USD | ? USD |
| 2021 | -42.1 million USD | ? USD |
| 2020 | -17.1 million USD | ? USD |
| 2019 | -9.5 million USD | ? USD |
EWTX
Price: $19.01
52 week price:
Earnings Per Share: -1.57 USD
P/E Ratio: -14.02
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 74985
Market Capitalization: 1.6 billion